Attention-Deficit Hyperactivity Disorder
19
0
2
13
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
0.0%
0 terminated out of 19 trials
100.0%
+13.5% vs benchmark
11%
2 trials in Phase 3/4
23%
3 of 13 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 13 completed trials
Clinical Trials (19)
Efficacy of Trigeminal Nerve Stimulation for ADHD
Tailored Yoga Therapy for Attention-deficit Hyperactivity Disorder
Families, Responsibility, Education, Support, and Health for Executive Function
The Efficacy of Equine Assisted Occupational Therapy for Children With Attention Deficit Hyperactivity Disorder (ADHD) on Cognitive-emotional Aspects, Daily Function and Participation
A Trial to Assess the Pharmacokinetics, Safety, and Tolerability of Centanafadine Capsules in Pediatric Subjects With Attention-deficit Hyperactivity Disorder
Autism Spectrum Disorder or Attention Deficit Hyperactivity Disorder in Covid-19 Outbreak
Technology-Enhanced Executive Functioning Intervention for ADHD
Pharmacokinetics of HLD200 in Children and Adolescents With ADHD
Lisdexamfetamine Dimesylate (LDX) Pilot Cognition Study to Evaluate the Utility of a Standardized Battery of Tests in Adults With Attention-Deficit Hyperactivity Disorder (ADHD)
Prevention of Comorbid Depression and Obesity in Attention-deficit/ Hyperactivity Disorder
Online Mindfulness-Based Intervention for ADHD
Impact of Relationship of Epilepsy and Attention Deficit Hyperactive Disorder
Cognitive Restructuring in ADHD: Functional Training
Johnston County ADHD Study: Environmental, Reporductive, and Familial Risk Factors for Attention-Deficit Hyperactivity Disorder (ADHD)
A Study to Examine the Progression of Attention-Deficit Hyperactivity Disorder (ADHD) Drug Treatment and to Analyze Associated Factors
A Phase II, Adaptive Trial Design Examining the Pharmacokinetic and Pharmacodynamic Effects of Modified Release Amphetamine (HLD100, Formulations B, C and E)) in Adolescents and Children With Attention-Deficit Hyperactivity Disorder (ADHD)
A Long-Term Study on Safety of JNS001 in Adults With Attention-Deficit Hyperactivity Disorder
An Efficacy and Safety Study for JNS001 in Adults With Attention-Deficit Hyperactivity Disorder
Working Memory Training in ADHD (The Engage Study)